GLUE SG&A Expenses

Monte Rosa Therapeutics Inc · SG&A Expenses

GLUE logo

GLUE SG&A Expenses

Latest reported$39.89M
GLUE SG&A Expenses ($644.00K → $39.89M)
High-resolution chart · PNG

GLUE sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
36,380,000
35,171,000
32,039,000
27,323,000
15,727,000
4,005,000
644,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.